相关实验视频

Updated: Jul 16, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

生药片通过Raf/ERK/ELK和HIF-1α/bFGF通道发挥抗乳腺增生作用

Yu-Fei Liu^1,2, Tian An³, Hong Yu¹

¹Beijing University of Chinese Medicine Third Affiliated Hospital, Beijing, China.

Journal of traditional and complementary medicine

|November 29, 2023

概括

生丸 (XZP) 通过调节激素水平和关键信号通路,有效治疗乳腺增生 (HMG). 通过抑制亡和血管生成,XZP显示出在管理HMG方面的潜力.

科学领域:

传统中国医药传统中国医药
药理学药理学是指药理学的学科.
内分泌学在内分泌学.

背景情况:

乳腺增生 (HMG) 是一种常见的疾病.
了解传统药物的治疗机制,如小镇药 (XZP) 是至关重要的.

研究的目的:

为了研究XZP对乳腺的抗增生效应.
确定XZP对HMG的行动中涉及的特定信号通路和分子点.

主要方法:

对XZP的化学成分分析.
检测激素水平 (E2,FSH,LH,P). 检测激素水平 (E2,FSH,LH,P). 检测激素水平 (E2,FSH,LH,P). 检测激素水平 (E2,FSH,LH,P). 检测激素水平.
对Raf/ERK/ELK和HIF-1α/bFGF通路的西部斑点分析.
对XZP对HMG代谢产物影响的代谢学分析.

主要成果:

在HMG小鼠中,XZP降低了E2,LH和FSH水平,同时增加了P.
XZP恢复了正常的乳腺组织结构,并调节了ER和PR的表达.
在Raf/ERK/ELK和HIF-1α/bFGF通路中,XZP干预降低了关键蛋白质的调节.
代谢分析表明,XZP调节了与HMG相关的代谢物和途径.

结论:

在乳腺上,XZP表现出抗增生效应.
通过抑制细胞亡和血管生成,XZP可能会产生其作用.
XZP的治疗作用与Raf/ERK/ELK和HIF-1α/bFGF信号通路的调节有关.
作为乳腺增生症的治疗方法,XZP显得有前途.

关键词:

血管新生的产生.细胞灭亡 (apoptosis) 是一种死亡的过程.乳腺腺增生症乳腺增生症代谢学代谢学代谢学小镇药丸 (XZP) 是一种药丸.

更多相关视频

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Published on: April 7, 2023

Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice

Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice

Published on: August 23, 2024

相关概念视频

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...

MAPK Signaling Cascades

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...

TGF - β Signaling Pathway

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...